Healthcare Professional Blog

Education Library

 

DanGer Shock Results from Dr. Jacob Møller at ACC 2024

Jacob Møller, MD, the principal investigator of the DanGer Shock trial, discusses study results he presented at ACC 2024.

Sign Up for Latest Updates

Stay up-to-date on the latest clinical data and resources.

All Posts

Filter Results

Condition

Audience

Topic

Type

Vasileios Panoulas, MD: Restoring EF in Daily Clinical Practice

Vasileios Panoulas, MD, presents 3 patient case examples illustrating significant LV improvement with PCI supported with Impella heart pumps.

Clinical Trial Update with Chuck Simonton, MD

Chuck Simonton, MD, provides an update on clinical trials including PROTECT III, RESTORE EF, and PROTECT IV RCT.

EACTS 2022 on Demand - MCS for PCCS, Structural Heart Disease, and Advanced Cardiogenic Shock

Discover the recordings of our scientific session at EACTS 2022 about "Innovative Strategies for Superior Outcome in Cardiac Surgery Including pMCS Support in Therapy Pathway".

Dr. Junya Ako: J-PVAD Registry and Data Presented at TCT 2022 

Junya Ako, MD, discusses the J-PVAD registry and study data presented at TCT 2022 with Prof. Hermann Reichenspurner.

Dr. Navin Kapur: Cardiogenic Shock Working Group and SCAI Shock Stages–TCT 2022

Navin Kapur, MD, provides an update from the Cardiogenic Shock Working Group and discusses the SCAI shock stages in this presentation from TCT 2022.

Dr. Katherine Kunkel: Best Practices in Cardiogenic Shock–TCT 2022

Katherine Kunkel, MD, discusses data-driven decision making and best practices in cardiogenic shock at TCT 2022. 

Dr. Navin Kapur: Lessons Learned in STEMI DTU™ Pilot Study–TCT 2022

Navin Kapur, MD, presents lessons learned in the STEMI DTU™ pilot trial in this presentation from TCT 2022. 

Live from TCT – September 17, 2022

Seth Bilazarian, MD, and Chuck Simonton, MD, recap highlights from day 1 of TCT 2022 and interview Greg Stone, MD and Alaide Chieffo, MD, FESC.

Dr. Kate Kearney: Contemporary Techniques for Optimal Outcomes in High-risk PCI–TCT 2022

Kate Kearney, MD, presents a case and discusses contemporary techniques for optimal outcomes in high-risk PCI at TCT 2022. 

Live from TCT – September 18, 2022

This recap of highlights from day 2 of TCT 2022 includes interviews with Drs. Sanjit Jolly, Navin Kapur, Adrian Attinger-Toller, and Taishi Hirai.

Live from TCT – September 19, 2022

Day 3 highlights from TCT 2022 include several late-breaking trials and interviews with Navin Kapur, MD, and Koichi Toda, MD, PhD.

TCT 2022: OPTIMUM Study Sub-Analysis Results

Adam Salisbury, MD, presents preliminary results from the OPTIMUM Study at TCT 2022.

Dr. Jonathan Hill: Influential Trials in High-risk PCI at TCT 2022

At TCT 2022, Jonathan Hill, MD, presents the influential high-risk PCI trials shaping the future of ischemic heart failure therapy.

81% Survival at 30 Days in a Multi-Center, Multi-Society Study of  of AMICS Patients Supported With Impella® Heart Pumps in Japan

Junya Ako, MD, presents outcomes in AMI cardiogenic shock from Japan’s J-PVAD study at TCT 2022.

TCT 2022: Data Integrity in Real-World Evidence

Robert Yeh, MD, discusses how we analyze data, make treatment decisions and participate in developing clinical evidence.

Subscribe for Our Healthcare Professional Newsletter

Subscribe for Our Healthcare Professional Newsletter

By subscribing you will receive our HeartRecovery newsletter for healthcare professionals with latest Impella® device news about recordings, interviews, upcoming and past events or clinical evidence.

CAMP PCI™

A Community Created by Physicians for Physicians

CAMP PCI was developed by physicians for physicians in an effort to respond to a growing crisis in coronary artery disease and heart failure.

Downloads

Discover further resources like brochures, data sheets and indications for use.

NPS-891

This information is intended for use by customers, patients, and healthcare professionals in [region] only. We recognize that the Internet is a global communications medium; however, laws, regulatory requirements, and product information for medical products can vary from country to country. The product information included here may not be appropriate for use outside [region], and the information from other sites you visit may not be appropriate for use in [region].